HUP0002826A2 - 6-Azauracil-származékok, eljárás előállításukra, alkalmazásuk gyulladások elleni gyógyszer előállítására és az ilyen kompozíciók - Google Patents
6-Azauracil-származékok, eljárás előállításukra, alkalmazásuk gyulladások elleni gyógyszer előállítására és az ilyen kompozíciókInfo
- Publication number
- HUP0002826A2 HUP0002826A2 HU0002826A HUP0002826A HUP0002826A2 HU P0002826 A2 HUP0002826 A2 HU P0002826A2 HU 0002826 A HU0002826 A HU 0002826A HU P0002826 A HUP0002826 A HU P0002826A HU P0002826 A2 HUP0002826 A2 HU P0002826A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- alkyl
- alkoxy
- general formula
- producing
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 208000027866 inflammatory disease Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- SSPYSWLZOPCOLO-UHFFFAOYSA-N 6-azauracil Chemical class O=C1C=NNC(=O)N1 SSPYSWLZOPCOLO-UHFFFAOYSA-N 0.000 title 1
- -1 mercapto- Chemical class 0.000 abstract 6
- 125000003118 aryl group Chemical group 0.000 abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 4
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 125000004414 alkyl thio group Chemical group 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 abstract 1
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 abstract 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 125000004984 dialkylaminoalkoxy group Chemical group 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 210000003979 eosinophil Anatomy 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 125000004441 haloalkylsulfonyl group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
- 229910052727 yttrium Inorganic materials 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0461—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Abstract
A találmány (I) általános képletű vegyületek, N-oxidjaik, gyógyászatiszempontból elfogadható addíciós sóik és sztereokémiai izomerjeikeozinofilfüggő gyulladásos betegségek kezelésére használhatógyógyszerek előállítására történő alkalmazására vonatkozik. Aképletben p értéke 0-4, q értéke 0-5, R1 jelentése hidrogénatom, alkil-, mono- vagy dialkil-amino-alkoxi-,merkapto-, alkil-tio-, cikloalkil-, arilcsoport, vagy pedig mono- vagydialkil-amino-, alkoxi- vagy arilcsoporttal vagy Het-csoporttalszubsztituált alkilcsoport, R2 jelentése cianocsoport vagy egy -C(=X)-Y-R5 általános képletűcsoport, ahol X jelentése O vagy S, Y jelentése O vagy S, vagy NR6általános képletű csoport vagy kovalens kötés, ahol R5 jelentése hidrogénatom, cikloalkil-, arilcsoport vagy adott esetbenhelyettesített alkilcsoport, és ha Y jelentése kovalens kötés, akkorR5 halogénatomot vagy Het-csoportot is jelenthet, R6 jelentése H, alkil-, alkoxi- vagy aril-alkil-csoport, R3 és R4 az egyes esetekben egymástól függetlenül halogénatomot,halogén-alkil-, alkil-, hidroxil-, alkoxi-, alkil-karbonil-oxi-,merkapto-, alkil-tio-, alkilszulfonil-, alkilszulfinil-, halogén-alkilszulfonil-, aril-, ciano-, nitro-, amino-, mono- vagy dialkil-amino- vagy alkil-karbonil-amino-csoportot jelent, az arilcsoportadott esetben helyettesített fenilcsoportot, Het pedig adott esetben helyettesített heterociklusos csoportotjelent. A találmány emellett az (I) általános képletű vegyületekszűkebb körét képező új vegyületekre, azok előállítási eljárására,valamint ilyen vegyületeket hatóanyagként tartalmazó kompozíciókravonatkozik. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97202117 | 1997-07-10 | ||
PCT/EP1998/004192 WO1999002504A1 (en) | 1997-07-10 | 1998-07-02 | 6-azauracil derivatives as il-5 inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0002826A2 true HUP0002826A2 (hu) | 2001-04-28 |
HUP0002826A3 HUP0002826A3 (en) | 2003-01-28 |
Family
ID=8228530
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0002826A HUP0002826A3 (en) | 1997-07-10 | 1998-07-02 | 6-azauracil derivatives, process for producing them, their use for producing medicament useful against inflammatory diseases and such compositions |
Country Status (20)
Country | Link |
---|---|
US (2) | US6743792B2 (hu) |
EP (1) | EP1003729A1 (hu) |
JP (1) | JP2002508001A (hu) |
KR (1) | KR20010012614A (hu) |
CN (1) | CN1261881A (hu) |
AU (1) | AU756637B2 (hu) |
BR (1) | BR9811499A (hu) |
CA (1) | CA2294533A1 (hu) |
EE (1) | EE9900585A (hu) |
HR (1) | HRP990333A2 (hu) |
HU (1) | HUP0002826A3 (hu) |
ID (1) | ID24224A (hu) |
IL (1) | IL133915A0 (hu) |
NO (1) | NO20000094L (hu) |
NZ (1) | NZ501627A (hu) |
PL (1) | PL337875A1 (hu) |
SK (1) | SK180999A3 (hu) |
TR (1) | TR199903249T2 (hu) |
WO (1) | WO1999002504A1 (hu) |
ZA (1) | ZA986095B (hu) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0987265A1 (en) | 1998-09-18 | 2000-03-22 | Janssen Pharmaceutica N.V. | Interleukin-5 inhibiting 6-azauracil derivatives |
US6469001B1 (en) | 1998-11-23 | 2002-10-22 | Eddy Jean Edgard Freyne | IL-5 inhibiting 6-azauracil derivatives |
HUP0104641A3 (en) | 1998-12-18 | 2003-01-28 | Janssen Pharmaceutica Nv | Il-5 inhibiting 6-azauracil derivatives process for their preparation and medicaments containing them |
ES2260031T3 (es) * | 1999-08-06 | 2006-11-01 | Janssen Pharmaceutica N.V. | Derivados de 6-azauracilo que inhiben la interleucina-5. |
US8073380B2 (en) * | 2005-12-30 | 2011-12-06 | Nokia Corporation | Media content delivery and recording over broadcast network |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3883527A (en) | 1973-10-19 | 1975-05-13 | Pfizer | Process for preparation of 2-aryl-1,3,4-triazine-3,5(2H,4H)-diones |
US4631278A (en) * | 1984-08-01 | 1986-12-23 | Janssen Pharmaceutica N.V. | Anti-protozoal α-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile derivatives, pharmaceutical compositions, and method of use therefor |
GB8602342D0 (en) * | 1986-01-30 | 1986-03-05 | Janssen Pharmaceutica Nv | 5 6-dihydro-2-(substituted phenyl)-1 2 4-triazine-3 5(2h 4h)-diones |
CA1331757C (en) * | 1988-02-29 | 1994-08-30 | Janssen Pharmaceutica Naamloze Vennootschap | 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols |
EP0476439A1 (de) * | 1990-09-18 | 1992-03-25 | Bayer Ag | Substituierte 1,2,4-Triazindione, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung |
DE4120138A1 (de) * | 1991-06-19 | 1992-12-24 | Bayer Ag | Substituierte hexahydro-1,2,4-triazindione, verfahren zu ihrer herstellung, zwischenprodukte dafuer und ihre verwendung |
TW263495B (hu) * | 1992-12-23 | 1995-11-21 | Celltech Ltd | |
GB9304920D0 (en) * | 1993-03-10 | 1993-04-28 | Celltech Ltd | Chemical compounds |
TW332201B (en) * | 1995-04-06 | 1998-05-21 | Janssen Pharmaceutica Nv | 1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives |
EP0737672B1 (en) * | 1995-04-14 | 2001-10-04 | Takeda Schering-Plough Animal Health K.K. | Method of producing triazine derivatives |
-
1998
- 1998-07-02 WO PCT/EP1998/004192 patent/WO1999002504A1/en not_active Application Discontinuation
- 1998-07-02 CA CA002294533A patent/CA2294533A1/en not_active Abandoned
- 1998-07-02 NZ NZ501627A patent/NZ501627A/en unknown
- 1998-07-02 TR TR1999/03249T patent/TR199903249T2/xx unknown
- 1998-07-02 ID IDW20000004A patent/ID24224A/id unknown
- 1998-07-02 BR BR9811499-9A patent/BR9811499A/pt not_active IP Right Cessation
- 1998-07-02 PL PL98337875A patent/PL337875A1/xx unknown
- 1998-07-02 CN CN98806918A patent/CN1261881A/zh active Pending
- 1998-07-02 JP JP50812799A patent/JP2002508001A/ja not_active Withdrawn
- 1998-07-02 KR KR1019997010573A patent/KR20010012614A/ko not_active Application Discontinuation
- 1998-07-02 SK SK1809-99A patent/SK180999A3/sk unknown
- 1998-07-02 EE EEP199900585A patent/EE9900585A/xx unknown
- 1998-07-02 HU HU0002826A patent/HUP0002826A3/hu unknown
- 1998-07-02 AU AU84413/98A patent/AU756637B2/en not_active Ceased
- 1998-07-02 EP EP98935022A patent/EP1003729A1/en not_active Withdrawn
- 1998-07-02 IL IL13391598A patent/IL133915A0/xx unknown
- 1998-07-09 ZA ZA9806095A patent/ZA986095B/xx unknown
-
1999
- 1999-10-29 HR HR97202117.4A patent/HRP990333A2/hr not_active Application Discontinuation
-
2000
- 2000-01-07 NO NO20000094A patent/NO20000094L/no unknown
-
2001
- 2001-05-14 US US09/855,068 patent/US6743792B2/en not_active Expired - Fee Related
-
2003
- 2003-05-09 US US10/434,896 patent/US6951857B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NZ501627A (en) | 2002-02-01 |
KR20010012614A (ko) | 2001-02-15 |
NO20000094L (no) | 2000-03-08 |
EP1003729A1 (en) | 2000-05-31 |
NO20000094D0 (no) | 2000-01-07 |
BR9811499A (pt) | 2000-09-19 |
CA2294533A1 (en) | 1999-01-21 |
JP2002508001A (ja) | 2002-03-12 |
US6951857B2 (en) | 2005-10-04 |
PL337875A1 (en) | 2000-09-11 |
US6743792B2 (en) | 2004-06-01 |
ID24224A (id) | 2000-07-13 |
EE9900585A (et) | 2000-08-15 |
HRP990333A2 (en) | 2000-04-30 |
WO1999002504A1 (en) | 1999-01-21 |
US20030220331A1 (en) | 2003-11-27 |
US20020042416A1 (en) | 2002-04-11 |
TR199903249T2 (xx) | 2000-09-21 |
CN1261881A (zh) | 2000-08-02 |
AU756637B2 (en) | 2003-01-16 |
ZA986095B (en) | 2000-01-10 |
SK180999A3 (en) | 2000-10-09 |
HUP0002826A3 (en) | 2003-01-28 |
IL133915A0 (en) | 2001-04-30 |
AU8441398A (en) | 1999-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO331068B1 (no) | Benzazepinderivater for behandling av nevrologiske forstyrrelser. | |
HUP0001507A2 (hu) | Pirrolo [2,3-d] pirimidin-származékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
HUP0002353A2 (hu) | IV típusú foszfodiészteráz inhibitor hatású 1-cikloalkil-1,8-naftiridin-4-on-származékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmények | |
HUP0303859A2 (hu) | Gombaellenes hatású vegyületek, intermedierjeik, előállításuk és alkalmazásuk | |
AP1822A (en) | Substituted pyridinones as modulators of P38 MAP kinase. | |
MY127066A (en) | Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors. | |
HUP0104200A2 (hu) | 2-amino-tiazol-származékok, eljárás előállításukra és tumorellenes szerekként történő felhasználásuk | |
HRP20041137B1 (hr) | Indolni, azaindolni i srodni heterocikliäśni 4-alkenil piperidinski amidi | |
UA48937C2 (uk) | Імідазолідини, заміщені гетероциклом, спосіб їх одержання і фармацевтична композиція, що їх містить | |
HUP0000189A2 (hu) | Biciklusos aril-karboxamid-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk terápiás célokra | |
HUP0002272A2 (hu) | Piperazinszármazékok, eljárás előállításukra, e vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
NZ505220A (en) | Arylpiperazines having activity at the serotonin 1A receptor, processes for their preparation and intermediates | |
ES2073398T3 (es) | Nuevos derivados substituidos del acido bencilideno- y cinamilideno-malonico con actividad como inhibidores de la proliferacion celular. | |
HUP0303034A2 (hu) | Új 7-azaindol-származékok, foszfodiészteráz-4 inhibitorjakénti alkalmazásuk és eljárás az előállításukra | |
AU2003218110A1 (en) | C3-cyano epothilone derivatives | |
HUP0004561A2 (hu) | Dihidrobenzofuránok és az ezeket tartalmazó gyógyszerkészítmények | |
WO2003082861A3 (en) | Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases | |
HUP0300677A2 (hu) | Újfajta indolszármazékok, és azok gyógyszerként történő alkalmazása és eljárás az előállításukra | |
ATE13178T1 (de) | 2-oxoazetidin-derivate, ihre herstellung und verwendung. | |
MXPA04005940A (es) | Acidos 3-(imidazolil)-2-aminopropanoicos. | |
HUP0003624A2 (hu) | 1,2,3,4-Tetrahidro-benzofuro[3,2-c]piridin-származékok, az ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra | |
AU3749495A (en) | Diazepino-indoles as phosphodiesterase iv inhibitors | |
HUP0301587A2 (hu) | Foszfodiészteráz V gátló hatású 5-amino-alkil-pirazolo[4,3-d]pirimidinek, ezeket tartalmazó gyógyszerkészítmények és eljárások az elżállításaikra | |
HUP0002826A2 (hu) | 6-Azauracil-származékok, eljárás előállításukra, alkalmazásuk gyulladások elleni gyógyszer előállítására és az ilyen kompozíciók | |
MXPA04003278A (es) | Derivados de 5-metoxi-8-aril-?1,2,4?triazolo?1,5-a?piridina como antagonistas del receptor de adenosina. |